Research-backed guides to peptides and health-optimization stacks — recovery, metabolic health, skin & hair, longevity. Real research, plain-English answers, and a source link on every claim. Then find research-grade suppliers.
New here? Start with the one-page map — the most-used peptide stacks, what the research actually says, and what to check before you buy.
No spam. Unsubscribe anytime.
What peptides actually are, the five biology words that do most of the work, why they’re injected instead of swallowed, how to read a peptide’s name, and how to tell research from marketing — in plain English, with every word defined.
Intro to Peptides →
On July 23–24, 2026, the FDA's Pharmacy Compounding Advisory Committee recommended adding six of seven reviewed peptides (BPC-157, KPV, TB-500, MOTS-c, Epitalon, Semax) to the Section 503A Bulks List and rejected Emideltide/DSIP. The vote is advisory only — not a final FDA decision and not legal authorization to compound. FDA must still complete formal notice-and-comment rulemaking (typically 12–24 months) before any change in legal status.
Read the full update →
Not sure where to start? Jump to the peptides studied for the goal you care about — recovery, metabolism, skin, and more.
The metabolic peptides behind the weight-management wave — GLP-1 and next-generation agonists — grouped with a neutral look at the evidence and how they differ. Every claim is sourced on each peptide's guide.
Explore this guide →
The peptides most discussed for tendon, ligament, muscle, and gut repair — grouped so you can see how they differ and where the research stands. Every claim is sourced on each peptide's own guide.
Explore this guide →
Peptides studied for skin regeneration, collagen, and hair — led by the copper peptide GHK-Cu. A neutral, sourced overview linking to each peptide's full guide.
Explore this guide →
Peptides studied for immune modulation and inflammatory balance — thymic and anti-inflammatory peptides — with a neutral look at the evidence. Every claim is sourced on each peptide's guide.
Explore this guide →
The peptides studied for amplifying the body's natural growth-hormone pulse — GHRH analogs and GHRPs — grouped so you can see how they differ and where the research stands. Every claim is sourced on each peptide's own guide.
Explore this guide →
Peptides and cofactors studied in cellular-aging, mitochondrial, and NAD+ research — grouped for a neutral look at where the science stands (much of it preclinical). Every claim is sourced on each peptide's guide.
Explore this guide →
Ranked by the depth of published research behind them — every claim links to a study you can verify yourself.
Insulin is a natural chemical messenger made by your body.…
Learn more →
Thymosin Alpha-1 is a small protein-like substance, called a peptide, that your body already makes.…
Learn more →
Semaglutide is a medicine that copies a natural body chemical called GLP-1.…
Learn more →
Oxytocin is a peptide, which means it is a short chain of tiny building blocks called amino acids.…
Learn more →
Tirzepatide is a medicine given as a weekly shot.…
Learn more →
BPC-157 is a man-made copy of a tiny piece of protein found in the stomach.…
Learn more →
BPC-157 + TB-500 — the most talked-about peptide combination in recovery research. Learn the science, see the sourced evidence, and compare suppliers.

Our content is built from PubMed studies, clinical guidelines, and established references — not marketing copy. Click any citation to verify it yourself.
Evidence-backed guides on peptides and stacks — with PubMed citations and a source link for every claim.
Explore our full library — benefits, side effects, and the research behind each compound, all in one place.
Our supplier pages list published COAs, price per mg, and clearly disclosed affiliate links.
New research suggests semaglutide's cardiovascular benefits may occur partly independently of its weight-loss effects. The GLP-1 receptor agonist, known for treating type 2 diabetes and obesity, appears to improve heart health through additional mechanisms. This may broaden its potential use in patients with cardiovascular disease.
Researchers report that an experimental peptide-based drug reversed myelin damage in a mouse model of multiple sclerosis, suggesting a possible repair-focused therapy. The findings come from preclinical work, and human trials have not yet begun. The approach is moving toward clinical translation.
Novo Nordisk announced topline results showing CagriSema, a fixed-dose combination of cagrilintide and semaglutide, produced greater weight loss than tirzepatide in adults with type 2 diabetes in the REIMAGINE 5 trial (12.4% vs. 9.1% at 60 weeks), while achieving noninferior HbA1c reductions. In the REDEFINE 9 trial, CagriSema led to 21% weight loss at 68 weeks in adults with overweight or obesity without diabetes. These are topline company-announced results from ongoing trial programs.
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.